Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 22, 2010 - Issue 6
286
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Budesonide enhances Toll-like receptor 2 expression in activated bronchial epithelial cells

, &
Pages 493-499 | Received 09 Oct 2009, Accepted 01 Dec 2009, Published online: 13 Apr 2010

References

  • Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783–801.
  • Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD, Millar AB. 2004. Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 31:241–245.
  • Bailey KL, Poole JA, Mathisen TL, Wyatt TA, Von Essen SG, Romberger DJ. 2008. Toll-like receptor 2 is upregulated by hog confinement dust in an IL-6-dependent manner in the airway epithelium. Am J Physiol Lung Cell Mol Physiol 294:L1049–L1054.
  • Bals R, Hiemstra PS. 2004. Innate immunity in the lung: How epithelial cells fight against respiratory pathogens. Eur Respir J 23:327–333.
  • Becker MN, Diamond G, Verghese MW, Randell SH. 2000. CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 275:29731–29736.
  • Ek A, Larsson K, Siljerud S, Palmberg L. 1999. Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages. Allergy 54:691–699.
  • Greene CM, McElvaney NG. 2005. Toll-like receptor expression and function in airway epithelial cells. Arch Immunol Ther Exp (Warsz) 53:418–427.
  • Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, Chignard M, Si-Tahar M. 2004. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: Evidence for an intracellular compartmentalization of TLR4. J Biol Chem 279:2712–2718.
  • Hermoso MA, Matsuguchi T, Smoak K, Cidlowski JA. 2004. Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression. Mol Cell Biol 24:4743–4756.
  • Homma T, Kato A, Hashimoto N, Batchelor J, Yoshikawa M, Imai S, Wakiguchi H, Saito H, Matsumoto K. 2004. Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells. Am J Respir Cell Mol Biol 31:463–469.
  • Imasato A, Desbois-Mouthon C, Han J, Kai H, Cato AC, Akira S, Li JD. 2002. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J Biol Chem 277:47444–47450.
  • Inoue K, Takano H, Yanagisawa R, Sakurai M, Shimada A, Morita T, Sato M, Yoshino S, Yoshikawa T. 2007. Role of interleukin-6 in toll-like receptor 4 and 2 expressions induced by lipopolysaccharide in the lung. Immunopharmacol Immunotoxicol 29:63–68.
  • Kwon OJ, Au BT, Collins PD, Baraniuk JN, Adcock IM, Chung KF, Barnes PJ. 1994. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. Immunology 81:389–394.
  • Larsson BM, Palmberg L, Malmberg PO, Larsson K. 1997. Effect of exposure to swine dust on levels of IL-8 in airway lavage fluid. Thorax 52:638–642.
  • Larsson K, Tornling G, Gavhed D, Muller-Suur C, Palmberg L. 1998. Inhalation of cold air increases the number of inflammatory cells in the lungs in healthy subjects. Eur Respir J 12:825–830.
  • LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M, Griffin GE, Ferrara P, Schiffrin EJ, Morgan BP, Labeta MO. 2003. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 171:6680–6689.
  • Levine SJ, Larivee P, Logun C, Angus CW, Shelhamer JH. 1993. Corticosteroids differentially regulate secretion of IL-6, IL-8, and G-CSF by a human bronchial epithelial cell line. Am J Physiol 265:L360–368.
  • Li JD. 2003. Exploitation of host epithelial signaling networks by respiratory bacterial pathogens. J Pharmacol Sci 91:1–7.
  • Palmberg L, Larsson BM, Malmberg P, Larsson K. 1998. Induction of IL-8 production in human alveolar macrophages and human bronchial epithelial cells in vitro by swine dust. Thorax 53:260–264.
  • Rosell A, Monso E, Soler N, Torres F, Angrill J, Riise G, Zalacain R, Morera J, Torres A. 2005. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 165:891–897.
  • Sakai A, Han J, Cato AC, Akira S, Li JD. 2004. Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP kinase phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells. BMC Mol Biol 5:2.
  • Schleimer RP. 1993. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 45(Suppl 1):S3-S7; discussion S43-S44.
  • Schulz C, Farkas L, Wolf K, Kratzel K, Eissner G, Pfeifer M. 2002. Differences in LPS-induced activation of bronchial epithelial cells (BEAS-2B) and type II-like pneumocytes (A-549). Scand J Immunol 56:294–302.
  • Shuto T, Imasato A, Jono H, Sakai A, Xu H, Watanabe T, Rixter DD, Kai H, Andalibi A, Linthicum F, Guan YL, Han J, Cato AC, Lim DJ, Akira S, Li JD. 2002. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem 277:17263–17270.
  • Srinivasan M, Kodumudi KN, Zunt SL. 2008. Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome. Clin Immunol 126:31–37.
  • Strandberg K, Palmberg L, Larsson K. 2007. Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells. Respir Med 101:1132–1139.
  • Wang Z, Larsson K, Palmberg L, Malmberg P, Larsson P, Larsson L. 1997. Inhalation of swine dust induces cytokine release in the upper and lower airways. Eur Respir J 10:381–387.
  • Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S. 2004. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522–1526.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.